| Product |
CAS |
Molecular formula |
More |
| [1-(6-Cyclopropylamino-pyrimidin-4-yl)-piperidin-2-ylmethyl ]-carbamic |
1353944-71-4 |
C18H29N5O2 |
More |
| [1-(6-Chloro-pyrimidin-4-yl)-piperidin-3-yl]-methanol |
939986-74-0 |
C10H14ClN3O |
More |
| [1-(6-Chloro-pyrimidin-4-yl)-piperidin-3-yl]-carbamic acid tert-butyl |
939986-09-1 |
C14H21ClN4O2 |
More |
| [1-(6-Chloro-pyridin-3-ylmethyl)-piperidin-4-yl]-carbamic acid tert-bu |
939986-36-4 |
C16H24ClN3O2 |
More |
| [1-(6-Chloro-pyridin-3-ylmethyl)-piperidin-3-yl]-methanol dihydrochlor |
1185312-32-6 |
C12H19Cl3N2O |
More |
| [1-(6-Chloro-pyridin-3-ylmethyl)-piperidin-3-yl]-carbamic acid tert-bu |
939986-37-5 |
C16H24ClN3O2 |
More |
| [1-(6-Chloro-pyridazin-3-yl)-piperidin-3-yl]-methanol |
939986-07-9 |
C10H14ClN3O |
More |
| [1-(6-Chloro-pyridazin-3-yl)-piperidin-3-yl]-carbamic acid tert-butyl |
939986-08-0 |
C14H21ClN4O2 |
More |
| [1-(5-Nitro-1h-benzoimidazol-2-yl)-piperidin-4-yl]-carbamic acid tert- |
1417794-13-8 |
C17H23N5O4 |
More |
| [1-(5-Bromo-pyridin-2-yl)-pyrrolidin-3-yl]-carbamic acid tert-butyl es |
1088410-93-8 |
C14H20BrN3O2 |
More |
| [1-(4-Trifluoromethyl-pyrimidin-2-yl)-piperidin-3-yl]-methanol |
916791-20-3 |
C11H14F3N3O |
More |
| [1-(4-Methyl-benzyl)-piperidin-4-yl]-methanol |
1211479-04-7 |
C14H21NO |
More |
| [1-(4-Methyl-benzyl)-piperidin-3-yl]-methanol |
415722-06-4 |
C14H21NO |
More |
| [1-(4-Methyl-benzyl)-piperidin-2-yl]-methanol |
1251236-70-0 |
C14H21NO |
More |
| [1-(4-Methoxy-benzyl)-piperidin-4-yl]-methyl-amine hydrochloride |
1185293-66-6 |
C14H22N2O.2[HCl] |
More |
| [1-(4-Methoxy-benzyl)-piperidin-4-yl]-methanol |
467123-20-7 |
|
More |
| [1-(4-Fluoro-phenyl)-ethyl ]-piperidin-4-ylmethyl-amine hydrochloride |
1185307-34-9 |
C14H22ClFN2 |
More |
| [1-(4-Fluoro-phenyl)-ethyl ]-piperidin-4-yl-amine hydrochloride |
1185317-19-4 |
C12H18ClFN2 |
More |
| [1-(4-Fluoro-phenyl)-ethyl ]-piperidin-3-ylmethyl-amine hydrochloride |
1185310-07-9 |
C14H22ClFN2 |
More |
| [1-(4-Fluoro-benzyl)-piperidin-4-yl]-methanol |
174561-04-7 |
C13H18FNO |
More |
